These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39121533)

  • 1. Asiaticoside modulates human NK cell functional fate by mediating metabolic flexibility in the tumor microenvironment.
    Guo Y; Xu J; Jia Y; Tian Y; Zhang Y; Zhang J; Wang Y; Chen L
    Phytomedicine; 2024 Oct; 133():155921. PubMed ID: 39121533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
    Wang Z; Guo L; Song Y; Zhang Y; Lin D; Hu B; Mei Y; Sandikin D; Liu H
    Cancer Immunol Immunother; 2017 Apr; 66(4):537-548. PubMed ID: 28184969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betulin Attenuates TGF-β1- and PGE
    Ogasawara M; Yamasaki-Yashiki S; Hamada M; Yamaguchi-Miyamoto T; Kawasuji T; Honda H; Yanagibashi T; Ikutani M; Watanabe Y; Fujimoto R; Matsunaga T; Nakajima N; Nagai Y; Takatsu K
    Biol Pharm Bull; 2022; 45(3):339-353. PubMed ID: 35228400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.
    Yvon ES; Burga R; Powell A; Cruz CR; Fernandes R; Barese C; Nguyen T; Abdel-Baki MS; Bollard CM
    Cytotherapy; 2017 Mar; 19(3):408-418. PubMed ID: 28109751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
    Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
    J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
    Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4
    Dimeloe S; Gubser P; Loeliger J; Frick C; Develioglu L; Fischer M; Marquardsen F; Bantug GR; Thommen D; Lecoultre Y; Zippelius A; Langenkamp A; Hess C
    Sci Signal; 2019 Sep; 12(599):. PubMed ID: 31530731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    Otegbeye F; Ojo E; Moreton S; Mackowski N; Lee DA; de Lima M; Wald DN
    PLoS One; 2018; 13(1):e0191358. PubMed ID: 29342200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.
    Trotta R; Dal Col J; Yu J; Ciarlariello D; Thomas B; Zhang X; Allard J; Wei M; Mao H; Byrd JC; Perrotti D; Caligiuri MA
    J Immunol; 2008 Sep; 181(6):3784-92. PubMed ID: 18768831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
    Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
    Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cajanine derivative LJ101019C regulates the proliferation and enhances the activity of NK cells via Kv1.3 channel-driven activation of the AKT/mTOR pathway.
    Geng J; Wang Y; Zhang L; Wang R; Li C; Sheng W; Li Z; Jiang M
    Phytomedicine; 2020 Jan; 66():153113. PubMed ID: 31790901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells.
    Choi SH; Cho HB; Choi JH; Kim HJ; Jang HJ; Cho S; Maeng E; Park H; Ryu KS; Park KH; Park KS
    J Control Release; 2024 Mar; 367():768-778. PubMed ID: 38341178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Inverse Relationship Between c-Kit/CD117 and mTOR Confers NK Cell Dysregulation Late After Severe Injury.
    Bösken B; Hepner-Schefczyk M; Vonderhagen S; Dudda M; Flohé SB
    Front Immunol; 2020; 11():1200. PubMed ID: 32670280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutations induce the suppression of CD8
    Huang H; Zhu X; Yu Y; Li Z; Yang Y; Xia L; Lu S
    J Transl Med; 2024 Jul; 22(1):653. PubMed ID: 39004699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF beta secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.
    Penafuerte C; Galipeau J
    Cancer Immunol Immunother; 2008 Aug; 57(8):1197-206. PubMed ID: 18214474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8
    Liu B; Zhu X; Kong L; Wang M; Spanoudis C; Chaturvedi P; George V; Jiao JA; You L; Egan JO; Echeverri C; Gallo VL; Xing J; Ravelo K; Prendes C; Antolinez J; Denissova J; Muniz GJ; Jeng EK; Rhode PR; Wong HC
    Mol Ther; 2021 Oct; 29(10):2949-2962. PubMed ID: 34091051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.